IGF1R and nasopharyngeal carcinoma: Mechanistically, overexpressed IGF1R promotes the resistance of NPC cells to radiotherapy by activating the IGF1R/ATK/S6 signaling pathway, which may become a potential target for radiosensitization therapy [64].